Here’s what you missed this week on Managed Healthcare Executive. Each Sunday we feature a highlight reel of various articles posted on our website that week.

CMS has balked at covering vagus nerve stimulation for treatment-resistant depression. Positive results from an ...

More than half (62.7%) of respondents reported facing financial barriers to obtaining their IBD medication.

The new guidelines consist of 145 recommendations for treating and managing premature ovarian insufficiency syndrome, which ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

A study published in The New England Journal of Medicine has demonstrated the potential of semaglutide for alleviating knee ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

A new study finds that that eczema can worsen when air quality drops from good to moderate levels on the Environmental ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Research at the annual meeting of the American Society of Hematology evaluated patient and caregiver perspectives on gene ...

Merck’s new pulmonary arterial hypertension (PAH) medication has posted another batch of promising clinical trial data, ...

The researchers found nearly half (47%) of the posts focused on efficacy, while 16% discussed adverse effects such as acne, ...